Ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine
C55H63F9N16O — CID 157063868
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine
Ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine (PubChem CID 157063868) has the molecular formula C55H63F9N16O and a molecular weight of 1135.20 g/mol. Its IUPAC name is ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine.
Molecular Properties
| Compound Name | Ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine |
|---|---|
| PubChem CID | 157063868 |
| Molecular Formula | C55H63F9N16O |
| Molecular Weight | 1135.20 g/mol |
| Exact Mass | 1134.52 |
| IUPAC Name | ethane;3-(2-piperazin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;3-(2-piperidin-1-ylpyrimidin-4-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine;4-[4-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]morpholine |
| SMILES | CC.CC.CC.FC(F)(F)c1ccc2ncc(-c3ccnc(N4CCCCC4)n3)n2c1.FC(F)(F)c1ccc2ncc(-c3ccnc(N4CCNCC4)n3)n2c1.FC(F)(F)c1ccc2ncc(-c3ccnc(N4CCOCC4)n3)n2c1 |
| InChI | InChI=1S/C17H16F3N5.C16H15F3N6.C16H14F3N5O.3C2H6/c18-17(19,20)12-4-5-15-22-10-14(25(15)11-12)13-6-7-21-16(23-13)24-8-2-1-3-9-24;17-16(18,19)11-1-2-14-22-9-13(25(14)10-11)12-3-4-21-15(23-12)24-7-5-20-6-8-24;17-16(18,19)11-1-2-14-21-9-13(24(14)10-11)12-3-4-20-15(22-12)23-5-7-25-8-6-23;3*1-2/h4-7,10-11H,1-3,8-9H2;1-4,9-10,20H,5-8H2;1-4,9-10H,5-8H2;3*1-2H3 |
| InChIKey | ABQIKUXEXOTHBW-UHFFFAOYSA-N |
| XLogP | 11.75 |
| TPSA | 160.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 81 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1135.20 |
| LogP ≤ 5 | 11.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157063868 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.